FDA Inspection
Cardinal Biologicals, Inc.Cardinal Biologicals, Inc. – FDA Inspection, Mar 27, 2013
Record Details
This FDA Inspection record concerns Cardinal Biologicals, Inc., with an inspection on March 27, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Cardinal Biologicals, Inc.
- Inspection Date
- March 27, 2013
- Product Type
- Biologics
View Company Profile
ID · ae01f5ef-8f9a-4b42-a8c6-eefa15ff16b1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 824267
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Cardinal Biologicals, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | Not classified | Kansas City District Office | Blood and Blood Products |
| February 6, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 24, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Cardinal Biologicals, Inc.
- FDA Inspection 1269612 - 2025-05-09
- FDA Inspection 1041210 - 2018-02-06
- FDA Inspection 974514 - 2016-05-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.